Wiegman A - Search Results

1

Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia.

Santos RD, Ruzza A, Hovingh GK, Wiegman A, Mach F, Kurtz CE, Hamer A, Bridges I, Bartuli A, Bergeron J, Szamosi T, Santra S, Stefanutti C, Descamps OS, Greber-Platzer S, Luirink I, Kastelein JJP, Gaudet D; HAUSER-RCT Investigators. Santos RD, et al. Among authors: wiegman a. N Engl J Med. 2020 Oct 1;383(14):1317-1327. doi: 10.1056/NEJMoa2019910. Epub 2020 Aug 29. N Engl J Med. 2020. PMID: 32865373 Clinical Trial.

2

[Is detection and treatment of familial hypercholesterolemia indicated in children?].

Bakker HD, Wiegman A, Defesche JC, Kastelein JJ. Bakker HD, et al. Among authors: wiegman a. Ned Tijdschr Geneeskd. 1997 Dec 27;141(52):2548-51. Ned Tijdschr Geneeskd. 1997. PMID: 9555154 Dutch.

3

The apolipoprotein epsilon4 allele confers additional risk in children with familial hypercholesterolemia.

Wiegman A, Sijbrands EJ, Rodenburg J, Defesche JC, de Jongh S, Bakker HD, Kastelein JJ. Wiegman A, et al. Pediatr Res. 2003 Jun;53(6):1008-12. doi: 10.1203/01.PDR.0000064580.23308.CB. Epub 2003 Mar 19. Pediatr Res. 2003. PMID: 12646733

4

Family history and cardiovascular risk in familial hypercholesterolemia: data in more than 1000 children.

Wiegman A, Rodenburg J, de Jongh S, Defesche JC, Bakker HD, Kastelein JJ, Sijbrands EJ. Wiegman A, et al. Circulation. 2003 Mar 25;107(11):1473-8. doi: 10.1161/01.cir.0000058166.99182.54. Circulation. 2003. PMID: 12654602

5

Surrogate markers of atherosclerosis: impact of statins.

Kastelein JJ, Wiegman A, de Groot E. Kastelein JJ, et al. Among authors: wiegman a. Atheroscler Suppl. 2003 Mar;4(1):31-6. doi: 10.1016/s1567-5688(03)00007-2. Atheroscler Suppl. 2003. PMID: 12714035 Review.

6

Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia.

Wiegman A, de Groot E, Hutten BA, Rodenburg J, Gort J, Bakker HD, Sijbrands EJ, Kastelein JJ. Wiegman A, et al. Lancet. 2004 Jan 31;363(9406):369-70. doi: 10.1016/S0140-6736(04)15467-6. Lancet. 2004. PMID: 15070569

7

Measurement of arterial wall thickness as a surrogate marker for atherosclerosis.

de Groot E, Hovingh GK, Wiegman A, Duriez P, Smit AJ, Fruchart JC, Kastelein JJ. de Groot E, et al. Among authors: wiegman a. Circulation. 2004 Jun 15;109(23 Suppl 1):III33-8. doi: 10.1161/01.CIR.0000131516.65699.ba. Circulation. 2004. PMID: 15198964 Review.

8

A boy with autosomal recessive hypercholesterolaemia.

Rodenburg J, Wiegman A, Vissers MN, Kastelein JJ, Stalenhoef AF. Rodenburg J, et al. Among authors: wiegman a. Neth J Med. 2004 Mar;62(3):89-93. Neth J Med. 2004. PMID: 15209474 Free article.

9

Familial hypercholesterolemia in children.

Rodenburg J, Vissers MN, Wiegman A, Trip MD, Bakker HD, Kastelein JJ. Rodenburg J, et al. Among authors: wiegman a. Curr Opin Lipidol. 2004 Aug;15(4):405-11. doi: 10.1097/01.mol.0000137228.92396.f3. Curr Opin Lipidol. 2004. PMID: 15243213 Review.

10

Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial.

Wiegman A, Hutten BA, de Groot E, Rodenburg J, Bakker HD, Büller HR, Sijbrands EJ, Kastelein JJ. Wiegman A, et al. JAMA. 2004 Jul 21;292(3):331-7. doi: 10.1001/jama.292.3.331. JAMA. 2004. PMID: 15265847 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

136 results

Search Page